Expression of human epidermal growth factor receptor 2 in bladder urothelial carcinoma.
Mohamed Reda El OchiMohamed OukabliElarbi BouaitiHafsa ChahdiAdil BoudhasMohamed AllaouiAhmed AmeurMohamed AbbarAbderrahmane Al BouzidiPublished in: BMC clinical pathology (2017)
HER2 protein overexpression is noted in patients with high grade cancer. This expression may select patients for anti HER2 targeted therapy. Future larger and prospective studies will verify the frequency of HER2 alteration and the role of HER2 in the aggressive behavior.
Keyphrases
- epidermal growth factor receptor
- high grade
- poor prognosis
- end stage renal disease
- tyrosine kinase
- binding protein
- endothelial cells
- advanced non small cell lung cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- spinal cord injury
- peritoneal dialysis
- papillary thyroid
- prognostic factors
- transcription factor
- squamous cell carcinoma
- current status
- young adults
- amino acid
- small molecule
- induced pluripotent stem cells
- squamous cell
- protein protein
- patient reported
- lymph node metastasis
- childhood cancer